Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster-randomized Controlled Trial Evaluating the Effects of Delaying Onset of Adolescent Substance Abuse on Cognitive Development and Addiction Following a Selective, Personality-targeted Intervention Programme: the Co-Venture Trial

NCT01655615 is registered in ClinicalTrials.gov with St. Justine's Hospital as lead sponsor.

NCT NCT01655615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01655615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster-randomized Controlled Trial Evaluating the Effects of Delaying Onset of Adolescent Substance Abuse on Cognitive Development and Addiction Following a Selective, Personality-targeted Intervention Programme: the Co-Venture Trial
Lead sponsor
St. Justine's Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2019
Enrollment
3,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol related disorders, substance related disorders